Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Revenue

Shanghai Junshi Biosciences had revenue of 969.92M CNY in the quarter ending June 30, 2026, with 45.24% growth. This brings the company's revenue in the last twelve months to 3.03B, up 29.85% year-over-year. In the year 2025, Shanghai Junshi Biosciences had annual revenue of 2.50B with 28.23% growth.

• Revenue (ttm): 3.03B CNY
• Revenue Growth: +29.85%
• P/S Ratio: 9.60
• Revenue / Employee: 990.59K CNY
• Employees: 3,055
• Market Cap: 33.53B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.50B	550.10M	28.23%
Dec 31, 2024	1.95B	445.77M	29.67%
Dec 31, 2023	1.50B	49.06M	3.38%
Dec 31, 2022	1.45B	-2.57B	-63.89%
Dec 31, 2021	4.02B	2.43B	152.36%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error